eBooks & Guides

Going small to win big: Fragment-based screening in drug discovery

Issue link: https://resources.nanotempertech.com/i/1133236

Contents of this Issue

Navigation

Page 11 of 20

12 X-ray Crystallography Considered the most sensitive screening technique in FBDD, it's also the only method that can provide details of the ligand binding site and the mode of binding. It's also the least susceptible to false positives. X-ray crystallography requires growing crystals of the target protein that are soaked in fragment samples at concentrations of up to 100 mM. Crystals are then rotated in a beam of X-rays to generate an electron density map capable of producing a three-dimensional model of the protein and any bound fragment. Formerly, X-ray crystallography was used to determine structure only as part of the optimization process a er hit detection was performed by other methods. But currently, it can be used as a high-throughput, front-line method for screening hits. Producing workable protein crystals, however, can be challenging and crystallized proteins may not be able to assume the same conformations in solution. Thus, there is a potential for obscuring binding sites resulting in false negatives. Most sensitive and best for providing details of binding site and mode of binding Crystallization of proteins remains challenging DWhen affinities become tight, one must also be very careful to optimize the regeneration conditions of the chip to

Articles in this issue

view archives of eBooks & Guides - Going small to win big: Fragment-based screening in drug discovery